Rituximab as pre-emptive therapy for EBV-reactivation following T-cell depleted allogeneic stem cell transplantation

Peccatori, J; Stanghellini, Ml; Bernardi, M; Ruggeri, A; Calbi, V; Servida, P; Rolla, S; Racca, S; Dominietto, A; Tedone, E; Soracco, M; Bregni, M; Ciceri, Fabio; Bacigalupo, A.